4
Changes in Ownership
Bicara Therapeutics Inc. Filed Acc 0001883986-25-000006
Chief Legal Officer sold 15,829 shares at $11.49 ($181,875)
- Chief Legal Officer acquired 15,829 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2025-09-15 | Option exercise 10b5-1 | +15,829 | $5.45 | $86,268 | 15,829 | D |
| Meisner Lara Chief Legal Officer | 2025-09-15 | Sale 10b5-1 | −15,829 | $11.49 | $181,875 | 0 | D |
| Derivatives | |||||||
| Meisner Lara Chief Legal Officer | 2025-09-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,085 | 54,769 | D | ||
| Meisner Lara Chief Legal Officer | 2025-09-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −9,744 | 87,699 | D | ||
| Open-market sales · 15,829 sh · avg $11.49 · $181,875 | |||||||
Loading xslF345X05/wk-form4_1758142866.xml…